ArticleJournal of gastrointestinal cancer2016
Complete Clinical Response of BRAF-Mutated Cholangiocarcinoma to Vemurafenib, Panitumumab, and Irinotecan.
Sergey V Silkin et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this paperpooled itcites it